BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21386784)

  • 1. From imaging to dosimetry and biological effects.
    Konijnenberg M
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):44-56. PubMed ID: 21386784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetry in nuclear medicine therapy: radiobiology application and results.
    Strigari L; Benassi M; Chiesa C; Cremonesi M; Bodei L; D'Andrea M
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):205-21. PubMed ID: 21386791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor control probability for tumor therapy with beta radionuclide interstitial injection.
    Chen Y; Geng J; Tian J; He Y; Chen S
    Biomed Mater Eng; 2004; 14(3):333-5. PubMed ID: 15299245
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent issues on dosimetry and radiobiology for peptide receptor radionuclide therapy.
    Cremonesi M; Ferrari M; Di Dia A; Botta F; De Cicco C; Bodei L; Paganelli G
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):155-67. PubMed ID: 21386788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides.
    Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):288-95. PubMed ID: 17043626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of radiotherapy using biological parameters.
    Kim Y; Tomé W
    Cancer Treat Res; 2008; 139():257-78. PubMed ID: 18236720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical dosimetry in the treatment of bone tumors: old and new agents.
    Hindorf C; Flux GD; Ibisch C; Kraeber Bodéré F
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):198-204. PubMed ID: 21386790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose painting and theragnostic imaging: towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology.
    Bentzen SM
    Cancer Treat Res; 2008; 139():41-62. PubMed ID: 18236711
    [No Abstract]   [Full Text] [Related]  

  • 9. Dosimetry in nuclear medicine therapy.
    Chiesa C; Lassmann M
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):2-4. PubMed ID: 21386781
    [No Abstract]   [Full Text] [Related]  

  • 10. Dosimetry in nuclear medicine therapy: what are the specifics in image quantification for dosimetry?
    Bardiès M; Buvat I
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):5-20. PubMed ID: 21386782
    [No Abstract]   [Full Text] [Related]  

  • 11. Dosimetry in Peptide radionuclide receptor therapy: a review.
    Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
    J Nucl Med; 2006 Sep; 47(9):1467-75. PubMed ID: 16954555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment planning in molecular radiotherapy.
    Glatting G; Bardiès M; Lassmann M
    Z Med Phys; 2013 Dec; 23(4):262-9. PubMed ID: 23597414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotargeting agents for cancer therapy.
    Kassis AI
    Expert Opin Drug Deliv; 2005 Nov; 2(6):981-91. PubMed ID: 16296803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy.
    Carlsson J; Eriksson V; Stenerlöw B; Lundqvist H
    Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1185-95. PubMed ID: 16718515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of dosimetry for Systemic Targeted Radionuclide Therapy (STaRT).
    Wessels BW; Syh JH; Meredith RF
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S39-45. PubMed ID: 16979438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan.
    Chiesa C; Maccauro M; Romito R; Spreafico C; Pellizzari S; Negri A; Sposito C; Morosi C; Civelli E; Lanocita R; Camerini T; Bampo C; Bhoori S; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):168-97. PubMed ID: 21386789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of stochastic fluctuation in radiation dose-rate on cell survival following fractionated radiation therapy.
    Paul S; Roy PK
    Phys Med Biol; 2012 Mar; 57(6):1561-73. PubMed ID: 22391148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships.
    El Naqa I; Suneja G; Lindsay PE; Hope AJ; Alaly JR; Vicic M; Bradley JD; Apte A; Deasy JO
    Phys Med Biol; 2006 Nov; 51(22):5719-35. PubMed ID: 17068361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetry of internal emitters.
    Sgouros G
    J Nucl Med; 2005 Jan; 46 Suppl 1():18S-27S. PubMed ID: 15653648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system.
    Lehmann J; Hartmann Siantar C; Wessol DE; Wemple CA; Nigg D; Cogliati J; Daly T; Descalle MA; Flickinger T; Pletcher D; Denardo G
    Phys Med Biol; 2005 Mar; 50(5):947-58. PubMed ID: 15798267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.